Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sytze T. Keizer"'
Autor:
Rosa Sloot, Maarten F. Schim van der Loeff, Erik W. van Zwet, Mariëlle C. Haks, Sytze T. Keizer, Maarten Scholing, Tom H.M. Ottenhoff, Martien W. Borgdorff, Simone A. Joosten
Publikováno v:
EBioMedicine, Vol 2, Iss 2, Pp 172-179 (2015)
Background: Current diagnostic tests cannot identify which infected individuals are at risk for progression to tuberculosis (TB). Our aim was to identify biomarkers which can predict the development of TB prior to clinical diagnosis. Method: In a ret
Externí odkaz:
https://doaj.org/article/da365b38f5a540a8bcd05f38d1a2c80c
Autor:
Mariëlle C. Haks, Martien W. Borgdorff, Tom H. M. Ottenhoff, Simone A. Joosten, Rosa Sloot, Erik W. van Zwet, Maarten F. Schim van der Loeff, Maarten Scholing, Sytze T. Keizer
Publikováno v:
EBioMedicine, 2(2), 172-179. Elsevier BV
EBioMedicine
EBioMedicine, Vol 2, Iss 2, Pp 172-179 (2015)
EBioMedicine
EBioMedicine, Vol 2, Iss 2, Pp 172-179 (2015)
Background Current diagnostic tests cannot identify which infected individuals are at risk for progression to tuberculosis (TB). Our aim was to identify biomarkers which can predict the development of TB prior to clinical diagnosis. Method In a retro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89a40794f57585fa78c3008c26fff508
https://pure.amc.nl/en/publications/biomarkers-can-identify-pulmonary-tuberculosis-in-hivinfected-drug-users-months-prior-to-clinical-diagnosis(9b4b51f3-7c88-4a2f-b8df-2fb58cdc011c).html
https://pure.amc.nl/en/publications/biomarkers-can-identify-pulmonary-tuberculosis-in-hivinfected-drug-users-months-prior-to-clinical-diagnosis(9b4b51f3-7c88-4a2f-b8df-2fb58cdc011c).html
Autor:
Marie-Christine Trompenaars, Martien W. Borgdorff, Hennie Baars, Rob van Hest, Sandra Kik, Marlies Mensen, Frank Cobelens, Paul J.H.J. van Gerven, Nico Kalisvaart, Sytze T. Keizer
Publikováno v:
Clinical infectious diseases, 39(4), 488-496. Oxford University Press
Background. Severe liver injury has been attributed to preventive treatment of latent tuberculosis infection with a 2-month course of rifampin-pyrazinamide. Methods. A retrospective cohort study in The Netherlands compared the hepatotoxicity of preve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de8274b583f462e1431c1c1f8770d59d
https://pubmed.ncbi.nlm.nih.gov/15356811
https://pubmed.ncbi.nlm.nih.gov/15356811